Filing Details
- Accession Number:
- 0001209191-11-028786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-16 21:56:05
- Reporting Period:
- 2011-05-12
- Filing Date:
- 2011-05-16
- Accepted Time:
- 2011-05-16 21:56:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1212689 | John Hodgman | 3280 Bayshore Blvd. Brisbane CA 94005 | Svp-Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-05-12 | 18,227 | $15.34 | 40,227 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2011-05-12 | 125,000 | $15.19 | 165,227 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-05-12 | 143,227 | $40.00 | 22,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-12 | 18,227 | $0.00 | 18,227 | $15.34 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-05-12 | 125,000 | $0.00 | 125,000 | $15.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,773 | 2018-05-13 | No | 4 | M | Direct | |
| 0 | 2016-08-14 | No | 4 | M | Direct |
Footnotes
- Twenty-five percent (25%) of the total number of shares subject to the stock option vest and become exercisable on the first anniversary of the grant date. The remainder of the option shares vests and becomes exercisable cumulatively in equal monthly installments over the following thirty-six (36) months.
- Fully exercisable.
Billionaire Hedge Funds
